FRONT GENET 润色咨询

Frontiers in Genetics

出版年份:暂无数据 年文章数:9811 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:1.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1199619, encodeId=53781199619b6, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:植物;遗传学;基因组学<br>经验分享:这是我最差的投稿体验,忍不住在这里吐槽一下。希望大家远离这个杂志。2021年11月1号投稿,编辑开始找了三个审稿人,全部给了小修的意见,2022年1月份修回后,三个审稿人全部认可了,包括润色费用也交了(用了他们推荐的润色服务)。最魔幻的来了,编辑又鬼使神差地找了另外2个审稿人,重新来一遍审稿流程,又花费了一个月,最后一个认可,一个拒稿意见,拒稿的这位审稿人极其不负责任,像是没读过论文,在审稿周期deadline的最后一刻,草草了事的写了几句话:这篇论文不行。我们修改完第四个审稿人的意见后,编辑又拖了2个周,就给拒了。。。拒了。。莫名其妙的给拒了,也就是说4个审稿人同意,一个不同意,给拒。。。按照这种无限找审稿人的做法,总有一个不认可你手稿的人,然后其他审稿人的意见都不听,直接给拒稿。<br>来来回回四个月,修改了七八次,润色也按照他们的要求做了,最后给你拒稿。给的理由极其不能让人信服。申诉都没地方去,这种杂志在开涮作者么?审稿就是个过场,编辑决定一切!希望投稿的人一些明灯,谨慎投稿。<br>另外,这个杂志已经铁定的中科院3区以下了,据不可靠消息中信所2021年也将该杂志列为预警名单。大家还是谨慎吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed955712032, createdName=ms1000001673566375, createdTime=Sat Mar 05 11:21:23 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227036, encodeId=bdd2122e0365c, content=问一下大家,是所有审稿人都审完了才可以提交修改后的文章是吧,交互论坛也没有开。目前只收到一个审稿人的意见,审稿进度显示Review is ongoing. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKiboeh23vhCNj6mpgnVvaMuttg0XFtg3tYNqn49fg91icLTbLlwDoqianeQXxwHvpe4mg4hpUM0ibh5w/132, createdBy=76fc2204943, createdName=飞天小女警, createdTime=Fri Jun 17 14:50:34 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056882, encodeId=895d1056882f9, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;基因;生物信息<br>经验分享:请问投稿时作者顺序把通讯弄成一作了怎么办,和手稿不一致,还没来的及跟编辑说,文章就已接收了,还没proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29775484328, createdName=wqqqqq, createdTime=Sat Oct 02 01:29:47 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205097, encodeId=6fa4120509e4b, content=偏重的研究方向:肺肿瘤<br>经验分享:请问非肿瘤纯生信还收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJhnQU5GWxeXOMO5JFcfQjuTfhjmpntBHASUp6pIzh7SfFPvNvhd9FNQyib6vKGJFicHLUhobumt2lQ/132, createdBy=01921810021, createdName=ms6239257544501925, createdTime=Wed Mar 23 03:21:54 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055926, encodeId=4d36105592603, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2950.0<br>偏重的研究方向:基因<br>经验分享:已经通过三个reviewers了;<br>等待associated editor的答复,<br>已经3天了,不知道还要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47905578868, createdName=ms3000001689908876, createdTime=Wed Sep 29 08:25:10 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589932, encodeId=e5965899321f, content=请问一下,你选择的是哪位助理编辑呢<span class="quote">136me530613(暂无昵称) 2020-04-06 00:00:00 发表:<br>Received date: 17 Jan 2020 Editorial assignment start date: 20 Jan 2020 Independent review start date: 30 Jan 2020 Interactive review activated date: 22 Feb 2020 Review finalized date: 02 Apr 2020 Final validation date: 06 Apr 2020 分享下第二篇的速度,感觉比第一篇快,之前选了一个冷门版块,所以稍微慢点。总得来说非常好中,即时因子估计有3.2,现在加紧灌吧。</span>, beContent=136me530613(暂无昵称) 2020-04-06 00:00:00 发表: Received date: 17 Jan 2020 Editorial assignment start date: 20 Jan 2020 Independent review start date: 30 Jan 2020 Interactive review activated date: 22 Feb 2020 Review finalized date: 02 Apr 2020 Final validation date: 06 Apr 2020 分享下第二篇的速度,感觉比第一篇快,之前选了一个冷门版块,所以稍微慢点。总得来说非常好中,即时因子估计有3.2,现在加紧灌吧。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a93b5330592, createdName=148cb1c4m26(暂无昵称), createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001531, encodeId=29e8100153175, content=审了几个月说我没发原始结果给他,发给了给他又说没收到,好不容易审稿修回,竟然被他拒了,没有理由的拒稿,由主编直接拒掉。超级水刊,下次再也不投,没见过这么垃圾的杂志。拉入黑名单, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f1135538142, createdName=caixiangsheng, createdTime=Wed Jul 21 22:49:14 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922417, encodeId=f67592241eee, content=大佬们纯生信还收嘛?让补实验还是直接拒稿?求告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=ms9000000284734747, createdTime=Wed Feb 03 10:35:30 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587238, encodeId=234158e238eb, content=我现在,第6个reviewer了。第一个提出大修,我修回去后,他竟然自动退出审稿了!!!任性!!!接着就是分配给第2,3个,他们,没有时间审。第4,5小修后,同意接收刊发。然而,这个时候突然冒出来第6个审稿人,非得要我用人的肾脏组织验证,我想说,我哪里来人的肾脏组织啊!我直接回复没有人体标本。就看上天保佑了!这么多审稿人,简直是要了命了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInv9SLAL0ztdtz7Uiax0cnwHGiblwiaUmkUmjXgHC0g3u5Bf7Tib6V2hpqnNbhKuNHFZYXa9JVqNBepg/132, createdBy=c01f1932823, createdName=地方, createdTime=Mon Mar 23 20:53:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574552, encodeId=923f5e4552af, content=7-22投稿,7-24转到另一个section,然后进入编辑处理阶段,8-8十几天没有任何消息,连编辑都没指定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/dc7b280f49af7fee2e92128f03a39234.jpg, createdBy=d2d11969271, createdName=hongweicheng, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=)]
    2022-03-05 ms1000001673566375

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:植物;遗传学;基因组学
    经验分享:这是我最差的投稿体验,忍不住在这里吐槽一下。希望大家远离这个杂志。2021年11月1号投稿,编辑开始找了三个审稿人,全部给了小修的意见,2022年1月份修回后,三个审稿人全部认可了,包括润色费用也交了(用了他们推荐的润色服务)。最魔幻的来了,编辑又鬼使神差地找了另外2个审稿人,重新来一遍审稿流程,又花费了一个月,最后一个认可,一个拒稿意见,拒稿的这位审稿人极其不负责任,像是没读过论文,在审稿周期deadline的最后一刻,草草了事的写了几句话:这篇论文不行。我们修改完第四个审稿人的意见后,编辑又拖了2个周,就给拒了。。。拒了。。莫名其妙的给拒了,也就是说4个审稿人同意,一个不同意,给拒。。。按照这种无限找审稿人的做法,总有一个不认可你手稿的人,然后其他审稿人的意见都不听,直接给拒稿。
    来来回回四个月,修改了七八次,润色也按照他们的要求做了,最后给你拒稿。给的理由极其不能让人信服。申诉都没地方去,这种杂志在开涮作者么?审稿就是个过场,编辑决定一切!希望投稿的人一些明灯,谨慎投稿。
    另外,这个杂志已经铁定的中科院3区以下了,据不可靠消息中信所2021年也将该杂志列为预警名单。大家还是谨慎吧。

    5

    展开5条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1199619, encodeId=53781199619b6, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:植物;遗传学;基因组学<br>经验分享:这是我最差的投稿体验,忍不住在这里吐槽一下。希望大家远离这个杂志。2021年11月1号投稿,编辑开始找了三个审稿人,全部给了小修的意见,2022年1月份修回后,三个审稿人全部认可了,包括润色费用也交了(用了他们推荐的润色服务)。最魔幻的来了,编辑又鬼使神差地找了另外2个审稿人,重新来一遍审稿流程,又花费了一个月,最后一个认可,一个拒稿意见,拒稿的这位审稿人极其不负责任,像是没读过论文,在审稿周期deadline的最后一刻,草草了事的写了几句话:这篇论文不行。我们修改完第四个审稿人的意见后,编辑又拖了2个周,就给拒了。。。拒了。。莫名其妙的给拒了,也就是说4个审稿人同意,一个不同意,给拒。。。按照这种无限找审稿人的做法,总有一个不认可你手稿的人,然后其他审稿人的意见都不听,直接给拒稿。<br>来来回回四个月,修改了七八次,润色也按照他们的要求做了,最后给你拒稿。给的理由极其不能让人信服。申诉都没地方去,这种杂志在开涮作者么?审稿就是个过场,编辑决定一切!希望投稿的人一些明灯,谨慎投稿。<br>另外,这个杂志已经铁定的中科院3区以下了,据不可靠消息中信所2021年也将该杂志列为预警名单。大家还是谨慎吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed955712032, createdName=ms1000001673566375, createdTime=Sat Mar 05 11:21:23 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227036, encodeId=bdd2122e0365c, content=问一下大家,是所有审稿人都审完了才可以提交修改后的文章是吧,交互论坛也没有开。目前只收到一个审稿人的意见,审稿进度显示Review is ongoing. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKiboeh23vhCNj6mpgnVvaMuttg0XFtg3tYNqn49fg91icLTbLlwDoqianeQXxwHvpe4mg4hpUM0ibh5w/132, createdBy=76fc2204943, createdName=飞天小女警, createdTime=Fri Jun 17 14:50:34 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056882, encodeId=895d1056882f9, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;基因;生物信息<br>经验分享:请问投稿时作者顺序把通讯弄成一作了怎么办,和手稿不一致,还没来的及跟编辑说,文章就已接收了,还没proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29775484328, createdName=wqqqqq, createdTime=Sat Oct 02 01:29:47 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205097, encodeId=6fa4120509e4b, content=偏重的研究方向:肺肿瘤<br>经验分享:请问非肿瘤纯生信还收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJhnQU5GWxeXOMO5JFcfQjuTfhjmpntBHASUp6pIzh7SfFPvNvhd9FNQyib6vKGJFicHLUhobumt2lQ/132, createdBy=01921810021, createdName=ms6239257544501925, createdTime=Wed Mar 23 03:21:54 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055926, encodeId=4d36105592603, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2950.0<br>偏重的研究方向:基因<br>经验分享:已经通过三个reviewers了;<br>等待associated editor的答复,<br>已经3天了,不知道还要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47905578868, createdName=ms3000001689908876, createdTime=Wed Sep 29 08:25:10 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589932, encodeId=e5965899321f, content=请问一下,你选择的是哪位助理编辑呢<span class="quote">136me530613(暂无昵称) 2020-04-06 00:00:00 发表:<br>Received date: 17 Jan 2020 Editorial assignment start date: 20 Jan 2020 Independent review start date: 30 Jan 2020 Interactive review activated date: 22 Feb 2020 Review finalized date: 02 Apr 2020 Final validation date: 06 Apr 2020 分享下第二篇的速度,感觉比第一篇快,之前选了一个冷门版块,所以稍微慢点。总得来说非常好中,即时因子估计有3.2,现在加紧灌吧。</span>, beContent=136me530613(暂无昵称) 2020-04-06 00:00:00 发表: Received date: 17 Jan 2020 Editorial assignment start date: 20 Jan 2020 Independent review start date: 30 Jan 2020 Interactive review activated date: 22 Feb 2020 Review finalized date: 02 Apr 2020 Final validation date: 06 Apr 2020 分享下第二篇的速度,感觉比第一篇快,之前选了一个冷门版块,所以稍微慢点。总得来说非常好中,即时因子估计有3.2,现在加紧灌吧。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a93b5330592, createdName=148cb1c4m26(暂无昵称), createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001531, encodeId=29e8100153175, content=审了几个月说我没发原始结果给他,发给了给他又说没收到,好不容易审稿修回,竟然被他拒了,没有理由的拒稿,由主编直接拒掉。超级水刊,下次再也不投,没见过这么垃圾的杂志。拉入黑名单, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f1135538142, createdName=caixiangsheng, createdTime=Wed Jul 21 22:49:14 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922417, encodeId=f67592241eee, content=大佬们纯生信还收嘛?让补实验还是直接拒稿?求告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=ms9000000284734747, createdTime=Wed Feb 03 10:35:30 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587238, encodeId=234158e238eb, content=我现在,第6个reviewer了。第一个提出大修,我修回去后,他竟然自动退出审稿了!!!任性!!!接着就是分配给第2,3个,他们,没有时间审。第4,5小修后,同意接收刊发。然而,这个时候突然冒出来第6个审稿人,非得要我用人的肾脏组织验证,我想说,我哪里来人的肾脏组织啊!我直接回复没有人体标本。就看上天保佑了!这么多审稿人,简直是要了命了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInv9SLAL0ztdtz7Uiax0cnwHGiblwiaUmkUmjXgHC0g3u5Bf7Tib6V2hpqnNbhKuNHFZYXa9JVqNBepg/132, createdBy=c01f1932823, createdName=地方, createdTime=Mon Mar 23 20:53:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574552, encodeId=923f5e4552af, content=7-22投稿,7-24转到另一个section,然后进入编辑处理阶段,8-8十几天没有任何消息,连编辑都没指定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/dc7b280f49af7fee2e92128f03a39234.jpg, createdBy=d2d11969271, createdName=hongweicheng, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=)]
    2022-06-17 飞天小女警

    问一下大家,是所有审稿人都审完了才可以提交修改后的文章是吧,交互论坛也没有开。目前只收到一个审稿人的意见,审稿进度显示Review is ongoing.

    5

    展开5条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1199619, encodeId=53781199619b6, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:植物;遗传学;基因组学<br>经验分享:这是我最差的投稿体验,忍不住在这里吐槽一下。希望大家远离这个杂志。2021年11月1号投稿,编辑开始找了三个审稿人,全部给了小修的意见,2022年1月份修回后,三个审稿人全部认可了,包括润色费用也交了(用了他们推荐的润色服务)。最魔幻的来了,编辑又鬼使神差地找了另外2个审稿人,重新来一遍审稿流程,又花费了一个月,最后一个认可,一个拒稿意见,拒稿的这位审稿人极其不负责任,像是没读过论文,在审稿周期deadline的最后一刻,草草了事的写了几句话:这篇论文不行。我们修改完第四个审稿人的意见后,编辑又拖了2个周,就给拒了。。。拒了。。莫名其妙的给拒了,也就是说4个审稿人同意,一个不同意,给拒。。。按照这种无限找审稿人的做法,总有一个不认可你手稿的人,然后其他审稿人的意见都不听,直接给拒稿。<br>来来回回四个月,修改了七八次,润色也按照他们的要求做了,最后给你拒稿。给的理由极其不能让人信服。申诉都没地方去,这种杂志在开涮作者么?审稿就是个过场,编辑决定一切!希望投稿的人一些明灯,谨慎投稿。<br>另外,这个杂志已经铁定的中科院3区以下了,据不可靠消息中信所2021年也将该杂志列为预警名单。大家还是谨慎吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed955712032, createdName=ms1000001673566375, createdTime=Sat Mar 05 11:21:23 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227036, encodeId=bdd2122e0365c, content=问一下大家,是所有审稿人都审完了才可以提交修改后的文章是吧,交互论坛也没有开。目前只收到一个审稿人的意见,审稿进度显示Review is ongoing. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKiboeh23vhCNj6mpgnVvaMuttg0XFtg3tYNqn49fg91icLTbLlwDoqianeQXxwHvpe4mg4hpUM0ibh5w/132, createdBy=76fc2204943, createdName=飞天小女警, createdTime=Fri Jun 17 14:50:34 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056882, encodeId=895d1056882f9, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;基因;生物信息<br>经验分享:请问投稿时作者顺序把通讯弄成一作了怎么办,和手稿不一致,还没来的及跟编辑说,文章就已接收了,还没proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29775484328, createdName=wqqqqq, createdTime=Sat Oct 02 01:29:47 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205097, encodeId=6fa4120509e4b, content=偏重的研究方向:肺肿瘤<br>经验分享:请问非肿瘤纯生信还收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJhnQU5GWxeXOMO5JFcfQjuTfhjmpntBHASUp6pIzh7SfFPvNvhd9FNQyib6vKGJFicHLUhobumt2lQ/132, createdBy=01921810021, createdName=ms6239257544501925, createdTime=Wed Mar 23 03:21:54 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055926, encodeId=4d36105592603, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2950.0<br>偏重的研究方向:基因<br>经验分享:已经通过三个reviewers了;<br>等待associated editor的答复,<br>已经3天了,不知道还要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47905578868, createdName=ms3000001689908876, createdTime=Wed Sep 29 08:25:10 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589932, encodeId=e5965899321f, content=请问一下,你选择的是哪位助理编辑呢<span class="quote">136me530613(暂无昵称) 2020-04-06 00:00:00 发表:<br>Received date: 17 Jan 2020 Editorial assignment start date: 20 Jan 2020 Independent review start date: 30 Jan 2020 Interactive review activated date: 22 Feb 2020 Review finalized date: 02 Apr 2020 Final validation date: 06 Apr 2020 分享下第二篇的速度,感觉比第一篇快,之前选了一个冷门版块,所以稍微慢点。总得来说非常好中,即时因子估计有3.2,现在加紧灌吧。</span>, beContent=136me530613(暂无昵称) 2020-04-06 00:00:00 发表: Received date: 17 Jan 2020 Editorial assignment start date: 20 Jan 2020 Independent review start date: 30 Jan 2020 Interactive review activated date: 22 Feb 2020 Review finalized date: 02 Apr 2020 Final validation date: 06 Apr 2020 分享下第二篇的速度,感觉比第一篇快,之前选了一个冷门版块,所以稍微慢点。总得来说非常好中,即时因子估计有3.2,现在加紧灌吧。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a93b5330592, createdName=148cb1c4m26(暂无昵称), createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001531, encodeId=29e8100153175, content=审了几个月说我没发原始结果给他,发给了给他又说没收到,好不容易审稿修回,竟然被他拒了,没有理由的拒稿,由主编直接拒掉。超级水刊,下次再也不投,没见过这么垃圾的杂志。拉入黑名单, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f1135538142, createdName=caixiangsheng, createdTime=Wed Jul 21 22:49:14 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922417, encodeId=f67592241eee, content=大佬们纯生信还收嘛?让补实验还是直接拒稿?求告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=ms9000000284734747, createdTime=Wed Feb 03 10:35:30 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587238, encodeId=234158e238eb, content=我现在,第6个reviewer了。第一个提出大修,我修回去后,他竟然自动退出审稿了!!!任性!!!接着就是分配给第2,3个,他们,没有时间审。第4,5小修后,同意接收刊发。然而,这个时候突然冒出来第6个审稿人,非得要我用人的肾脏组织验证,我想说,我哪里来人的肾脏组织啊!我直接回复没有人体标本。就看上天保佑了!这么多审稿人,简直是要了命了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInv9SLAL0ztdtz7Uiax0cnwHGiblwiaUmkUmjXgHC0g3u5Bf7Tib6V2hpqnNbhKuNHFZYXa9JVqNBepg/132, createdBy=c01f1932823, createdName=地方, createdTime=Mon Mar 23 20:53:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574552, encodeId=923f5e4552af, content=7-22投稿,7-24转到另一个section,然后进入编辑处理阶段,8-8十几天没有任何消息,连编辑都没指定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/dc7b280f49af7fee2e92128f03a39234.jpg, createdBy=d2d11969271, createdName=hongweicheng, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=)]
    2021-10-02 wqqqqq

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:分子生物学;基因;生物信息
    经验分享:请问投稿时作者顺序把通讯弄成一作了怎么办,和手稿不一致,还没来的及跟编辑说,文章就已接收了,还没proof

    5

    展开5条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1199619, encodeId=53781199619b6, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:植物;遗传学;基因组学<br>经验分享:这是我最差的投稿体验,忍不住在这里吐槽一下。希望大家远离这个杂志。2021年11月1号投稿,编辑开始找了三个审稿人,全部给了小修的意见,2022年1月份修回后,三个审稿人全部认可了,包括润色费用也交了(用了他们推荐的润色服务)。最魔幻的来了,编辑又鬼使神差地找了另外2个审稿人,重新来一遍审稿流程,又花费了一个月,最后一个认可,一个拒稿意见,拒稿的这位审稿人极其不负责任,像是没读过论文,在审稿周期deadline的最后一刻,草草了事的写了几句话:这篇论文不行。我们修改完第四个审稿人的意见后,编辑又拖了2个周,就给拒了。。。拒了。。莫名其妙的给拒了,也就是说4个审稿人同意,一个不同意,给拒。。。按照这种无限找审稿人的做法,总有一个不认可你手稿的人,然后其他审稿人的意见都不听,直接给拒稿。<br>来来回回四个月,修改了七八次,润色也按照他们的要求做了,最后给你拒稿。给的理由极其不能让人信服。申诉都没地方去,这种杂志在开涮作者么?审稿就是个过场,编辑决定一切!希望投稿的人一些明灯,谨慎投稿。<br>另外,这个杂志已经铁定的中科院3区以下了,据不可靠消息中信所2021年也将该杂志列为预警名单。大家还是谨慎吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed955712032, createdName=ms1000001673566375, createdTime=Sat Mar 05 11:21:23 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227036, encodeId=bdd2122e0365c, content=问一下大家,是所有审稿人都审完了才可以提交修改后的文章是吧,交互论坛也没有开。目前只收到一个审稿人的意见,审稿进度显示Review is ongoing. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKiboeh23vhCNj6mpgnVvaMuttg0XFtg3tYNqn49fg91icLTbLlwDoqianeQXxwHvpe4mg4hpUM0ibh5w/132, createdBy=76fc2204943, createdName=飞天小女警, createdTime=Fri Jun 17 14:50:34 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056882, encodeId=895d1056882f9, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;基因;生物信息<br>经验分享:请问投稿时作者顺序把通讯弄成一作了怎么办,和手稿不一致,还没来的及跟编辑说,文章就已接收了,还没proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29775484328, createdName=wqqqqq, createdTime=Sat Oct 02 01:29:47 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205097, encodeId=6fa4120509e4b, content=偏重的研究方向:肺肿瘤<br>经验分享:请问非肿瘤纯生信还收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJhnQU5GWxeXOMO5JFcfQjuTfhjmpntBHASUp6pIzh7SfFPvNvhd9FNQyib6vKGJFicHLUhobumt2lQ/132, createdBy=01921810021, createdName=ms6239257544501925, createdTime=Wed Mar 23 03:21:54 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055926, encodeId=4d36105592603, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2950.0<br>偏重的研究方向:基因<br>经验分享:已经通过三个reviewers了;<br>等待associated editor的答复,<br>已经3天了,不知道还要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47905578868, createdName=ms3000001689908876, createdTime=Wed Sep 29 08:25:10 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589932, encodeId=e5965899321f, content=请问一下,你选择的是哪位助理编辑呢<span class="quote">136me530613(暂无昵称) 2020-04-06 00:00:00 发表:<br>Received date: 17 Jan 2020 Editorial assignment start date: 20 Jan 2020 Independent review start date: 30 Jan 2020 Interactive review activated date: 22 Feb 2020 Review finalized date: 02 Apr 2020 Final validation date: 06 Apr 2020 分享下第二篇的速度,感觉比第一篇快,之前选了一个冷门版块,所以稍微慢点。总得来说非常好中,即时因子估计有3.2,现在加紧灌吧。</span>, beContent=136me530613(暂无昵称) 2020-04-06 00:00:00 发表: Received date: 17 Jan 2020 Editorial assignment start date: 20 Jan 2020 Independent review start date: 30 Jan 2020 Interactive review activated date: 22 Feb 2020 Review finalized date: 02 Apr 2020 Final validation date: 06 Apr 2020 分享下第二篇的速度,感觉比第一篇快,之前选了一个冷门版块,所以稍微慢点。总得来说非常好中,即时因子估计有3.2,现在加紧灌吧。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a93b5330592, createdName=148cb1c4m26(暂无昵称), createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001531, encodeId=29e8100153175, content=审了几个月说我没发原始结果给他,发给了给他又说没收到,好不容易审稿修回,竟然被他拒了,没有理由的拒稿,由主编直接拒掉。超级水刊,下次再也不投,没见过这么垃圾的杂志。拉入黑名单, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f1135538142, createdName=caixiangsheng, createdTime=Wed Jul 21 22:49:14 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922417, encodeId=f67592241eee, content=大佬们纯生信还收嘛?让补实验还是直接拒稿?求告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=ms9000000284734747, createdTime=Wed Feb 03 10:35:30 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587238, encodeId=234158e238eb, content=我现在,第6个reviewer了。第一个提出大修,我修回去后,他竟然自动退出审稿了!!!任性!!!接着就是分配给第2,3个,他们,没有时间审。第4,5小修后,同意接收刊发。然而,这个时候突然冒出来第6个审稿人,非得要我用人的肾脏组织验证,我想说,我哪里来人的肾脏组织啊!我直接回复没有人体标本。就看上天保佑了!这么多审稿人,简直是要了命了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInv9SLAL0ztdtz7Uiax0cnwHGiblwiaUmkUmjXgHC0g3u5Bf7Tib6V2hpqnNbhKuNHFZYXa9JVqNBepg/132, createdBy=c01f1932823, createdName=地方, createdTime=Mon Mar 23 20:53:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574552, encodeId=923f5e4552af, content=7-22投稿,7-24转到另一个section,然后进入编辑处理阶段,8-8十几天没有任何消息,连编辑都没指定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/dc7b280f49af7fee2e92128f03a39234.jpg, createdBy=d2d11969271, createdName=hongweicheng, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=)]
    2022-03-23 ms6239257544501925

    偏重的研究方向:肺肿瘤
    经验分享:请问非肿瘤纯生信还收吗

    5

    展开5条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1199619, encodeId=53781199619b6, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:植物;遗传学;基因组学<br>经验分享:这是我最差的投稿体验,忍不住在这里吐槽一下。希望大家远离这个杂志。2021年11月1号投稿,编辑开始找了三个审稿人,全部给了小修的意见,2022年1月份修回后,三个审稿人全部认可了,包括润色费用也交了(用了他们推荐的润色服务)。最魔幻的来了,编辑又鬼使神差地找了另外2个审稿人,重新来一遍审稿流程,又花费了一个月,最后一个认可,一个拒稿意见,拒稿的这位审稿人极其不负责任,像是没读过论文,在审稿周期deadline的最后一刻,草草了事的写了几句话:这篇论文不行。我们修改完第四个审稿人的意见后,编辑又拖了2个周,就给拒了。。。拒了。。莫名其妙的给拒了,也就是说4个审稿人同意,一个不同意,给拒。。。按照这种无限找审稿人的做法,总有一个不认可你手稿的人,然后其他审稿人的意见都不听,直接给拒稿。<br>来来回回四个月,修改了七八次,润色也按照他们的要求做了,最后给你拒稿。给的理由极其不能让人信服。申诉都没地方去,这种杂志在开涮作者么?审稿就是个过场,编辑决定一切!希望投稿的人一些明灯,谨慎投稿。<br>另外,这个杂志已经铁定的中科院3区以下了,据不可靠消息中信所2021年也将该杂志列为预警名单。大家还是谨慎吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed955712032, createdName=ms1000001673566375, createdTime=Sat Mar 05 11:21:23 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227036, encodeId=bdd2122e0365c, content=问一下大家,是所有审稿人都审完了才可以提交修改后的文章是吧,交互论坛也没有开。目前只收到一个审稿人的意见,审稿进度显示Review is ongoing. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKiboeh23vhCNj6mpgnVvaMuttg0XFtg3tYNqn49fg91icLTbLlwDoqianeQXxwHvpe4mg4hpUM0ibh5w/132, createdBy=76fc2204943, createdName=飞天小女警, createdTime=Fri Jun 17 14:50:34 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056882, encodeId=895d1056882f9, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;基因;生物信息<br>经验分享:请问投稿时作者顺序把通讯弄成一作了怎么办,和手稿不一致,还没来的及跟编辑说,文章就已接收了,还没proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29775484328, createdName=wqqqqq, createdTime=Sat Oct 02 01:29:47 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205097, encodeId=6fa4120509e4b, content=偏重的研究方向:肺肿瘤<br>经验分享:请问非肿瘤纯生信还收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJhnQU5GWxeXOMO5JFcfQjuTfhjmpntBHASUp6pIzh7SfFPvNvhd9FNQyib6vKGJFicHLUhobumt2lQ/132, createdBy=01921810021, createdName=ms6239257544501925, createdTime=Wed Mar 23 03:21:54 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055926, encodeId=4d36105592603, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2950.0<br>偏重的研究方向:基因<br>经验分享:已经通过三个reviewers了;<br>等待associated editor的答复,<br>已经3天了,不知道还要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47905578868, createdName=ms3000001689908876, createdTime=Wed Sep 29 08:25:10 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589932, encodeId=e5965899321f, content=请问一下,你选择的是哪位助理编辑呢<span class="quote">136me530613(暂无昵称) 2020-04-06 00:00:00 发表:<br>Received date: 17 Jan 2020 Editorial assignment start date: 20 Jan 2020 Independent review start date: 30 Jan 2020 Interactive review activated date: 22 Feb 2020 Review finalized date: 02 Apr 2020 Final validation date: 06 Apr 2020 分享下第二篇的速度,感觉比第一篇快,之前选了一个冷门版块,所以稍微慢点。总得来说非常好中,即时因子估计有3.2,现在加紧灌吧。</span>, beContent=136me530613(暂无昵称) 2020-04-06 00:00:00 发表: Received date: 17 Jan 2020 Editorial assignment start date: 20 Jan 2020 Independent review start date: 30 Jan 2020 Interactive review activated date: 22 Feb 2020 Review finalized date: 02 Apr 2020 Final validation date: 06 Apr 2020 分享下第二篇的速度,感觉比第一篇快,之前选了一个冷门版块,所以稍微慢点。总得来说非常好中,即时因子估计有3.2,现在加紧灌吧。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a93b5330592, createdName=148cb1c4m26(暂无昵称), createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001531, encodeId=29e8100153175, content=审了几个月说我没发原始结果给他,发给了给他又说没收到,好不容易审稿修回,竟然被他拒了,没有理由的拒稿,由主编直接拒掉。超级水刊,下次再也不投,没见过这么垃圾的杂志。拉入黑名单, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f1135538142, createdName=caixiangsheng, createdTime=Wed Jul 21 22:49:14 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922417, encodeId=f67592241eee, content=大佬们纯生信还收嘛?让补实验还是直接拒稿?求告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=ms9000000284734747, createdTime=Wed Feb 03 10:35:30 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587238, encodeId=234158e238eb, content=我现在,第6个reviewer了。第一个提出大修,我修回去后,他竟然自动退出审稿了!!!任性!!!接着就是分配给第2,3个,他们,没有时间审。第4,5小修后,同意接收刊发。然而,这个时候突然冒出来第6个审稿人,非得要我用人的肾脏组织验证,我想说,我哪里来人的肾脏组织啊!我直接回复没有人体标本。就看上天保佑了!这么多审稿人,简直是要了命了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInv9SLAL0ztdtz7Uiax0cnwHGiblwiaUmkUmjXgHC0g3u5Bf7Tib6V2hpqnNbhKuNHFZYXa9JVqNBepg/132, createdBy=c01f1932823, createdName=地方, createdTime=Mon Mar 23 20:53:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574552, encodeId=923f5e4552af, content=7-22投稿,7-24转到另一个section,然后进入编辑处理阶段,8-8十几天没有任何消息,连编辑都没指定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/dc7b280f49af7fee2e92128f03a39234.jpg, createdBy=d2d11969271, createdName=hongweicheng, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=)]
    2021-09-29 ms3000001689908876

    审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2950.0
    偏重的研究方向:基因
    经验分享:已经通过三个reviewers了;
    等待associated editor的答复,
    已经3天了,不知道还要多久啊?

    5

    展开5条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1199619, encodeId=53781199619b6, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:植物;遗传学;基因组学<br>经验分享:这是我最差的投稿体验,忍不住在这里吐槽一下。希望大家远离这个杂志。2021年11月1号投稿,编辑开始找了三个审稿人,全部给了小修的意见,2022年1月份修回后,三个审稿人全部认可了,包括润色费用也交了(用了他们推荐的润色服务)。最魔幻的来了,编辑又鬼使神差地找了另外2个审稿人,重新来一遍审稿流程,又花费了一个月,最后一个认可,一个拒稿意见,拒稿的这位审稿人极其不负责任,像是没读过论文,在审稿周期deadline的最后一刻,草草了事的写了几句话:这篇论文不行。我们修改完第四个审稿人的意见后,编辑又拖了2个周,就给拒了。。。拒了。。莫名其妙的给拒了,也就是说4个审稿人同意,一个不同意,给拒。。。按照这种无限找审稿人的做法,总有一个不认可你手稿的人,然后其他审稿人的意见都不听,直接给拒稿。<br>来来回回四个月,修改了七八次,润色也按照他们的要求做了,最后给你拒稿。给的理由极其不能让人信服。申诉都没地方去,这种杂志在开涮作者么?审稿就是个过场,编辑决定一切!希望投稿的人一些明灯,谨慎投稿。<br>另外,这个杂志已经铁定的中科院3区以下了,据不可靠消息中信所2021年也将该杂志列为预警名单。大家还是谨慎吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed955712032, createdName=ms1000001673566375, createdTime=Sat Mar 05 11:21:23 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227036, encodeId=bdd2122e0365c, content=问一下大家,是所有审稿人都审完了才可以提交修改后的文章是吧,交互论坛也没有开。目前只收到一个审稿人的意见,审稿进度显示Review is ongoing. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKiboeh23vhCNj6mpgnVvaMuttg0XFtg3tYNqn49fg91icLTbLlwDoqianeQXxwHvpe4mg4hpUM0ibh5w/132, createdBy=76fc2204943, createdName=飞天小女警, createdTime=Fri Jun 17 14:50:34 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056882, encodeId=895d1056882f9, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;基因;生物信息<br>经验分享:请问投稿时作者顺序把通讯弄成一作了怎么办,和手稿不一致,还没来的及跟编辑说,文章就已接收了,还没proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29775484328, createdName=wqqqqq, createdTime=Sat Oct 02 01:29:47 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205097, encodeId=6fa4120509e4b, content=偏重的研究方向:肺肿瘤<br>经验分享:请问非肿瘤纯生信还收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJhnQU5GWxeXOMO5JFcfQjuTfhjmpntBHASUp6pIzh7SfFPvNvhd9FNQyib6vKGJFicHLUhobumt2lQ/132, createdBy=01921810021, createdName=ms6239257544501925, createdTime=Wed Mar 23 03:21:54 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055926, encodeId=4d36105592603, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2950.0<br>偏重的研究方向:基因<br>经验分享:已经通过三个reviewers了;<br>等待associated editor的答复,<br>已经3天了,不知道还要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47905578868, createdName=ms3000001689908876, createdTime=Wed Sep 29 08:25:10 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589932, encodeId=e5965899321f, content=请问一下,你选择的是哪位助理编辑呢<span class="quote">136me530613(暂无昵称) 2020-04-06 00:00:00 发表:<br>Received date: 17 Jan 2020 Editorial assignment start date: 20 Jan 2020 Independent review start date: 30 Jan 2020 Interactive review activated date: 22 Feb 2020 Review finalized date: 02 Apr 2020 Final validation date: 06 Apr 2020 分享下第二篇的速度,感觉比第一篇快,之前选了一个冷门版块,所以稍微慢点。总得来说非常好中,即时因子估计有3.2,现在加紧灌吧。</span>, beContent=136me530613(暂无昵称) 2020-04-06 00:00:00 发表: Received date: 17 Jan 2020 Editorial assignment start date: 20 Jan 2020 Independent review start date: 30 Jan 2020 Interactive review activated date: 22 Feb 2020 Review finalized date: 02 Apr 2020 Final validation date: 06 Apr 2020 分享下第二篇的速度,感觉比第一篇快,之前选了一个冷门版块,所以稍微慢点。总得来说非常好中,即时因子估计有3.2,现在加紧灌吧。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a93b5330592, createdName=148cb1c4m26(暂无昵称), createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001531, encodeId=29e8100153175, content=审了几个月说我没发原始结果给他,发给了给他又说没收到,好不容易审稿修回,竟然被他拒了,没有理由的拒稿,由主编直接拒掉。超级水刊,下次再也不投,没见过这么垃圾的杂志。拉入黑名单, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f1135538142, createdName=caixiangsheng, createdTime=Wed Jul 21 22:49:14 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922417, encodeId=f67592241eee, content=大佬们纯生信还收嘛?让补实验还是直接拒稿?求告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=ms9000000284734747, createdTime=Wed Feb 03 10:35:30 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587238, encodeId=234158e238eb, content=我现在,第6个reviewer了。第一个提出大修,我修回去后,他竟然自动退出审稿了!!!任性!!!接着就是分配给第2,3个,他们,没有时间审。第4,5小修后,同意接收刊发。然而,这个时候突然冒出来第6个审稿人,非得要我用人的肾脏组织验证,我想说,我哪里来人的肾脏组织啊!我直接回复没有人体标本。就看上天保佑了!这么多审稿人,简直是要了命了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInv9SLAL0ztdtz7Uiax0cnwHGiblwiaUmkUmjXgHC0g3u5Bf7Tib6V2hpqnNbhKuNHFZYXa9JVqNBepg/132, createdBy=c01f1932823, createdName=地方, createdTime=Mon Mar 23 20:53:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574552, encodeId=923f5e4552af, content=7-22投稿,7-24转到另一个section,然后进入编辑处理阶段,8-8十几天没有任何消息,连编辑都没指定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/dc7b280f49af7fee2e92128f03a39234.jpg, createdBy=d2d11969271, createdName=hongweicheng, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=)]
    2020-04-29 148cb1c4m26(暂无昵称)

    请问一下,你选择的是哪位助理编辑呢136me530613(暂无昵称) 2020-04-06 00:00:00 发表:
    Received date: 17 Jan 2020 Editorial assignment start date: 20 Jan 2020 Independent review start date: 30 Jan 2020 Interactive review activated date: 22 Feb 2020 Review finalized date: 02 Apr 2020 Final validation date: 06 Apr 2020 分享下第二篇的速度,感觉比第一篇快,之前选了一个冷门版块,所以稍微慢点。总得来说非常好中,即时因子估计有3.2,现在加紧灌吧。

    136me530613(暂无昵称) 2020-04-06 00:00:00 发表: Received date: 17 Jan 2020 Editorial assignment start date: 20 Jan 2020 Independent review start date: 30 Jan 2020 Interactive review activated date: 22 Feb 2020 Review finalized date: 02 Apr 2020 Final validation date: 06 Apr 2020 分享下第二篇的速度,感觉比第一篇快,之前选了一个冷门版块,所以稍微慢点。总得来说非常好中,即时因子估计有3.2,现在加紧灌吧。

    5

    展开5条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1199619, encodeId=53781199619b6, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:植物;遗传学;基因组学<br>经验分享:这是我最差的投稿体验,忍不住在这里吐槽一下。希望大家远离这个杂志。2021年11月1号投稿,编辑开始找了三个审稿人,全部给了小修的意见,2022年1月份修回后,三个审稿人全部认可了,包括润色费用也交了(用了他们推荐的润色服务)。最魔幻的来了,编辑又鬼使神差地找了另外2个审稿人,重新来一遍审稿流程,又花费了一个月,最后一个认可,一个拒稿意见,拒稿的这位审稿人极其不负责任,像是没读过论文,在审稿周期deadline的最后一刻,草草了事的写了几句话:这篇论文不行。我们修改完第四个审稿人的意见后,编辑又拖了2个周,就给拒了。。。拒了。。莫名其妙的给拒了,也就是说4个审稿人同意,一个不同意,给拒。。。按照这种无限找审稿人的做法,总有一个不认可你手稿的人,然后其他审稿人的意见都不听,直接给拒稿。<br>来来回回四个月,修改了七八次,润色也按照他们的要求做了,最后给你拒稿。给的理由极其不能让人信服。申诉都没地方去,这种杂志在开涮作者么?审稿就是个过场,编辑决定一切!希望投稿的人一些明灯,谨慎投稿。<br>另外,这个杂志已经铁定的中科院3区以下了,据不可靠消息中信所2021年也将该杂志列为预警名单。大家还是谨慎吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed955712032, createdName=ms1000001673566375, createdTime=Sat Mar 05 11:21:23 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227036, encodeId=bdd2122e0365c, content=问一下大家,是所有审稿人都审完了才可以提交修改后的文章是吧,交互论坛也没有开。目前只收到一个审稿人的意见,审稿进度显示Review is ongoing. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKiboeh23vhCNj6mpgnVvaMuttg0XFtg3tYNqn49fg91icLTbLlwDoqianeQXxwHvpe4mg4hpUM0ibh5w/132, createdBy=76fc2204943, createdName=飞天小女警, createdTime=Fri Jun 17 14:50:34 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056882, encodeId=895d1056882f9, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;基因;生物信息<br>经验分享:请问投稿时作者顺序把通讯弄成一作了怎么办,和手稿不一致,还没来的及跟编辑说,文章就已接收了,还没proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29775484328, createdName=wqqqqq, createdTime=Sat Oct 02 01:29:47 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205097, encodeId=6fa4120509e4b, content=偏重的研究方向:肺肿瘤<br>经验分享:请问非肿瘤纯生信还收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJhnQU5GWxeXOMO5JFcfQjuTfhjmpntBHASUp6pIzh7SfFPvNvhd9FNQyib6vKGJFicHLUhobumt2lQ/132, createdBy=01921810021, createdName=ms6239257544501925, createdTime=Wed Mar 23 03:21:54 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055926, encodeId=4d36105592603, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2950.0<br>偏重的研究方向:基因<br>经验分享:已经通过三个reviewers了;<br>等待associated editor的答复,<br>已经3天了,不知道还要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47905578868, createdName=ms3000001689908876, createdTime=Wed Sep 29 08:25:10 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589932, encodeId=e5965899321f, content=请问一下,你选择的是哪位助理编辑呢<span class="quote">136me530613(暂无昵称) 2020-04-06 00:00:00 发表:<br>Received date: 17 Jan 2020 Editorial assignment start date: 20 Jan 2020 Independent review start date: 30 Jan 2020 Interactive review activated date: 22 Feb 2020 Review finalized date: 02 Apr 2020 Final validation date: 06 Apr 2020 分享下第二篇的速度,感觉比第一篇快,之前选了一个冷门版块,所以稍微慢点。总得来说非常好中,即时因子估计有3.2,现在加紧灌吧。</span>, beContent=136me530613(暂无昵称) 2020-04-06 00:00:00 发表: Received date: 17 Jan 2020 Editorial assignment start date: 20 Jan 2020 Independent review start date: 30 Jan 2020 Interactive review activated date: 22 Feb 2020 Review finalized date: 02 Apr 2020 Final validation date: 06 Apr 2020 分享下第二篇的速度,感觉比第一篇快,之前选了一个冷门版块,所以稍微慢点。总得来说非常好中,即时因子估计有3.2,现在加紧灌吧。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a93b5330592, createdName=148cb1c4m26(暂无昵称), createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001531, encodeId=29e8100153175, content=审了几个月说我没发原始结果给他,发给了给他又说没收到,好不容易审稿修回,竟然被他拒了,没有理由的拒稿,由主编直接拒掉。超级水刊,下次再也不投,没见过这么垃圾的杂志。拉入黑名单, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f1135538142, createdName=caixiangsheng, createdTime=Wed Jul 21 22:49:14 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922417, encodeId=f67592241eee, content=大佬们纯生信还收嘛?让补实验还是直接拒稿?求告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=ms9000000284734747, createdTime=Wed Feb 03 10:35:30 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587238, encodeId=234158e238eb, content=我现在,第6个reviewer了。第一个提出大修,我修回去后,他竟然自动退出审稿了!!!任性!!!接着就是分配给第2,3个,他们,没有时间审。第4,5小修后,同意接收刊发。然而,这个时候突然冒出来第6个审稿人,非得要我用人的肾脏组织验证,我想说,我哪里来人的肾脏组织啊!我直接回复没有人体标本。就看上天保佑了!这么多审稿人,简直是要了命了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInv9SLAL0ztdtz7Uiax0cnwHGiblwiaUmkUmjXgHC0g3u5Bf7Tib6V2hpqnNbhKuNHFZYXa9JVqNBepg/132, createdBy=c01f1932823, createdName=地方, createdTime=Mon Mar 23 20:53:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574552, encodeId=923f5e4552af, content=7-22投稿,7-24转到另一个section,然后进入编辑处理阶段,8-8十几天没有任何消息,连编辑都没指定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/dc7b280f49af7fee2e92128f03a39234.jpg, createdBy=d2d11969271, createdName=hongweicheng, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=)]
    2021-07-21 caixiangsheng

    审了几个月说我没发原始结果给他,发给了给他又说没收到,好不容易审稿修回,竟然被他拒了,没有理由的拒稿,由主编直接拒掉。超级水刊,下次再也不投,没见过这么垃圾的杂志。拉入黑名单

    5

    展开5条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1199619, encodeId=53781199619b6, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:植物;遗传学;基因组学<br>经验分享:这是我最差的投稿体验,忍不住在这里吐槽一下。希望大家远离这个杂志。2021年11月1号投稿,编辑开始找了三个审稿人,全部给了小修的意见,2022年1月份修回后,三个审稿人全部认可了,包括润色费用也交了(用了他们推荐的润色服务)。最魔幻的来了,编辑又鬼使神差地找了另外2个审稿人,重新来一遍审稿流程,又花费了一个月,最后一个认可,一个拒稿意见,拒稿的这位审稿人极其不负责任,像是没读过论文,在审稿周期deadline的最后一刻,草草了事的写了几句话:这篇论文不行。我们修改完第四个审稿人的意见后,编辑又拖了2个周,就给拒了。。。拒了。。莫名其妙的给拒了,也就是说4个审稿人同意,一个不同意,给拒。。。按照这种无限找审稿人的做法,总有一个不认可你手稿的人,然后其他审稿人的意见都不听,直接给拒稿。<br>来来回回四个月,修改了七八次,润色也按照他们的要求做了,最后给你拒稿。给的理由极其不能让人信服。申诉都没地方去,这种杂志在开涮作者么?审稿就是个过场,编辑决定一切!希望投稿的人一些明灯,谨慎投稿。<br>另外,这个杂志已经铁定的中科院3区以下了,据不可靠消息中信所2021年也将该杂志列为预警名单。大家还是谨慎吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed955712032, createdName=ms1000001673566375, createdTime=Sat Mar 05 11:21:23 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227036, encodeId=bdd2122e0365c, content=问一下大家,是所有审稿人都审完了才可以提交修改后的文章是吧,交互论坛也没有开。目前只收到一个审稿人的意见,审稿进度显示Review is ongoing. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKiboeh23vhCNj6mpgnVvaMuttg0XFtg3tYNqn49fg91icLTbLlwDoqianeQXxwHvpe4mg4hpUM0ibh5w/132, createdBy=76fc2204943, createdName=飞天小女警, createdTime=Fri Jun 17 14:50:34 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056882, encodeId=895d1056882f9, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;基因;生物信息<br>经验分享:请问投稿时作者顺序把通讯弄成一作了怎么办,和手稿不一致,还没来的及跟编辑说,文章就已接收了,还没proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29775484328, createdName=wqqqqq, createdTime=Sat Oct 02 01:29:47 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205097, encodeId=6fa4120509e4b, content=偏重的研究方向:肺肿瘤<br>经验分享:请问非肿瘤纯生信还收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJhnQU5GWxeXOMO5JFcfQjuTfhjmpntBHASUp6pIzh7SfFPvNvhd9FNQyib6vKGJFicHLUhobumt2lQ/132, createdBy=01921810021, createdName=ms6239257544501925, createdTime=Wed Mar 23 03:21:54 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055926, encodeId=4d36105592603, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2950.0<br>偏重的研究方向:基因<br>经验分享:已经通过三个reviewers了;<br>等待associated editor的答复,<br>已经3天了,不知道还要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47905578868, createdName=ms3000001689908876, createdTime=Wed Sep 29 08:25:10 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589932, encodeId=e5965899321f, content=请问一下,你选择的是哪位助理编辑呢<span class="quote">136me530613(暂无昵称) 2020-04-06 00:00:00 发表:<br>Received date: 17 Jan 2020 Editorial assignment start date: 20 Jan 2020 Independent review start date: 30 Jan 2020 Interactive review activated date: 22 Feb 2020 Review finalized date: 02 Apr 2020 Final validation date: 06 Apr 2020 分享下第二篇的速度,感觉比第一篇快,之前选了一个冷门版块,所以稍微慢点。总得来说非常好中,即时因子估计有3.2,现在加紧灌吧。</span>, beContent=136me530613(暂无昵称) 2020-04-06 00:00:00 发表: Received date: 17 Jan 2020 Editorial assignment start date: 20 Jan 2020 Independent review start date: 30 Jan 2020 Interactive review activated date: 22 Feb 2020 Review finalized date: 02 Apr 2020 Final validation date: 06 Apr 2020 分享下第二篇的速度,感觉比第一篇快,之前选了一个冷门版块,所以稍微慢点。总得来说非常好中,即时因子估计有3.2,现在加紧灌吧。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a93b5330592, createdName=148cb1c4m26(暂无昵称), createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001531, encodeId=29e8100153175, content=审了几个月说我没发原始结果给他,发给了给他又说没收到,好不容易审稿修回,竟然被他拒了,没有理由的拒稿,由主编直接拒掉。超级水刊,下次再也不投,没见过这么垃圾的杂志。拉入黑名单, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f1135538142, createdName=caixiangsheng, createdTime=Wed Jul 21 22:49:14 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922417, encodeId=f67592241eee, content=大佬们纯生信还收嘛?让补实验还是直接拒稿?求告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=ms9000000284734747, createdTime=Wed Feb 03 10:35:30 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587238, encodeId=234158e238eb, content=我现在,第6个reviewer了。第一个提出大修,我修回去后,他竟然自动退出审稿了!!!任性!!!接着就是分配给第2,3个,他们,没有时间审。第4,5小修后,同意接收刊发。然而,这个时候突然冒出来第6个审稿人,非得要我用人的肾脏组织验证,我想说,我哪里来人的肾脏组织啊!我直接回复没有人体标本。就看上天保佑了!这么多审稿人,简直是要了命了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInv9SLAL0ztdtz7Uiax0cnwHGiblwiaUmkUmjXgHC0g3u5Bf7Tib6V2hpqnNbhKuNHFZYXa9JVqNBepg/132, createdBy=c01f1932823, createdName=地方, createdTime=Mon Mar 23 20:53:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574552, encodeId=923f5e4552af, content=7-22投稿,7-24转到另一个section,然后进入编辑处理阶段,8-8十几天没有任何消息,连编辑都没指定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/dc7b280f49af7fee2e92128f03a39234.jpg, createdBy=d2d11969271, createdName=hongweicheng, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=)]
    2021-02-03 ms9000000284734747

    大佬们纯生信还收嘛?让补实验还是直接拒稿?求告知

    5

    展开5条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1199619, encodeId=53781199619b6, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:植物;遗传学;基因组学<br>经验分享:这是我最差的投稿体验,忍不住在这里吐槽一下。希望大家远离这个杂志。2021年11月1号投稿,编辑开始找了三个审稿人,全部给了小修的意见,2022年1月份修回后,三个审稿人全部认可了,包括润色费用也交了(用了他们推荐的润色服务)。最魔幻的来了,编辑又鬼使神差地找了另外2个审稿人,重新来一遍审稿流程,又花费了一个月,最后一个认可,一个拒稿意见,拒稿的这位审稿人极其不负责任,像是没读过论文,在审稿周期deadline的最后一刻,草草了事的写了几句话:这篇论文不行。我们修改完第四个审稿人的意见后,编辑又拖了2个周,就给拒了。。。拒了。。莫名其妙的给拒了,也就是说4个审稿人同意,一个不同意,给拒。。。按照这种无限找审稿人的做法,总有一个不认可你手稿的人,然后其他审稿人的意见都不听,直接给拒稿。<br>来来回回四个月,修改了七八次,润色也按照他们的要求做了,最后给你拒稿。给的理由极其不能让人信服。申诉都没地方去,这种杂志在开涮作者么?审稿就是个过场,编辑决定一切!希望投稿的人一些明灯,谨慎投稿。<br>另外,这个杂志已经铁定的中科院3区以下了,据不可靠消息中信所2021年也将该杂志列为预警名单。大家还是谨慎吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed955712032, createdName=ms1000001673566375, createdTime=Sat Mar 05 11:21:23 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227036, encodeId=bdd2122e0365c, content=问一下大家,是所有审稿人都审完了才可以提交修改后的文章是吧,交互论坛也没有开。目前只收到一个审稿人的意见,审稿进度显示Review is ongoing. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKiboeh23vhCNj6mpgnVvaMuttg0XFtg3tYNqn49fg91icLTbLlwDoqianeQXxwHvpe4mg4hpUM0ibh5w/132, createdBy=76fc2204943, createdName=飞天小女警, createdTime=Fri Jun 17 14:50:34 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056882, encodeId=895d1056882f9, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;基因;生物信息<br>经验分享:请问投稿时作者顺序把通讯弄成一作了怎么办,和手稿不一致,还没来的及跟编辑说,文章就已接收了,还没proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29775484328, createdName=wqqqqq, createdTime=Sat Oct 02 01:29:47 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205097, encodeId=6fa4120509e4b, content=偏重的研究方向:肺肿瘤<br>经验分享:请问非肿瘤纯生信还收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJhnQU5GWxeXOMO5JFcfQjuTfhjmpntBHASUp6pIzh7SfFPvNvhd9FNQyib6vKGJFicHLUhobumt2lQ/132, createdBy=01921810021, createdName=ms6239257544501925, createdTime=Wed Mar 23 03:21:54 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055926, encodeId=4d36105592603, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2950.0<br>偏重的研究方向:基因<br>经验分享:已经通过三个reviewers了;<br>等待associated editor的答复,<br>已经3天了,不知道还要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47905578868, createdName=ms3000001689908876, createdTime=Wed Sep 29 08:25:10 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589932, encodeId=e5965899321f, content=请问一下,你选择的是哪位助理编辑呢<span class="quote">136me530613(暂无昵称) 2020-04-06 00:00:00 发表:<br>Received date: 17 Jan 2020 Editorial assignment start date: 20 Jan 2020 Independent review start date: 30 Jan 2020 Interactive review activated date: 22 Feb 2020 Review finalized date: 02 Apr 2020 Final validation date: 06 Apr 2020 分享下第二篇的速度,感觉比第一篇快,之前选了一个冷门版块,所以稍微慢点。总得来说非常好中,即时因子估计有3.2,现在加紧灌吧。</span>, beContent=136me530613(暂无昵称) 2020-04-06 00:00:00 发表: Received date: 17 Jan 2020 Editorial assignment start date: 20 Jan 2020 Independent review start date: 30 Jan 2020 Interactive review activated date: 22 Feb 2020 Review finalized date: 02 Apr 2020 Final validation date: 06 Apr 2020 分享下第二篇的速度,感觉比第一篇快,之前选了一个冷门版块,所以稍微慢点。总得来说非常好中,即时因子估计有3.2,现在加紧灌吧。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a93b5330592, createdName=148cb1c4m26(暂无昵称), createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001531, encodeId=29e8100153175, content=审了几个月说我没发原始结果给他,发给了给他又说没收到,好不容易审稿修回,竟然被他拒了,没有理由的拒稿,由主编直接拒掉。超级水刊,下次再也不投,没见过这么垃圾的杂志。拉入黑名单, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f1135538142, createdName=caixiangsheng, createdTime=Wed Jul 21 22:49:14 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922417, encodeId=f67592241eee, content=大佬们纯生信还收嘛?让补实验还是直接拒稿?求告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=ms9000000284734747, createdTime=Wed Feb 03 10:35:30 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587238, encodeId=234158e238eb, content=我现在,第6个reviewer了。第一个提出大修,我修回去后,他竟然自动退出审稿了!!!任性!!!接着就是分配给第2,3个,他们,没有时间审。第4,5小修后,同意接收刊发。然而,这个时候突然冒出来第6个审稿人,非得要我用人的肾脏组织验证,我想说,我哪里来人的肾脏组织啊!我直接回复没有人体标本。就看上天保佑了!这么多审稿人,简直是要了命了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInv9SLAL0ztdtz7Uiax0cnwHGiblwiaUmkUmjXgHC0g3u5Bf7Tib6V2hpqnNbhKuNHFZYXa9JVqNBepg/132, createdBy=c01f1932823, createdName=地方, createdTime=Mon Mar 23 20:53:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574552, encodeId=923f5e4552af, content=7-22投稿,7-24转到另一个section,然后进入编辑处理阶段,8-8十几天没有任何消息,连编辑都没指定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/dc7b280f49af7fee2e92128f03a39234.jpg, createdBy=d2d11969271, createdName=hongweicheng, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=)]
    2020-03-23 地方

    我现在,第6个reviewer了。第一个提出大修,我修回去后,他竟然自动退出审稿了!!!任性!!!接着就是分配给第2,3个,他们,没有时间审。第4,5小修后,同意接收刊发。然而,这个时候突然冒出来第6个审稿人,非得要我用人的肾脏组织验证,我想说,我哪里来人的肾脏组织啊!我直接回复没有人体标本。就看上天保佑了!这么多审稿人,简直是要了命了!

    5

    展开5条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1199619, encodeId=53781199619b6, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:植物;遗传学;基因组学<br>经验分享:这是我最差的投稿体验,忍不住在这里吐槽一下。希望大家远离这个杂志。2021年11月1号投稿,编辑开始找了三个审稿人,全部给了小修的意见,2022年1月份修回后,三个审稿人全部认可了,包括润色费用也交了(用了他们推荐的润色服务)。最魔幻的来了,编辑又鬼使神差地找了另外2个审稿人,重新来一遍审稿流程,又花费了一个月,最后一个认可,一个拒稿意见,拒稿的这位审稿人极其不负责任,像是没读过论文,在审稿周期deadline的最后一刻,草草了事的写了几句话:这篇论文不行。我们修改完第四个审稿人的意见后,编辑又拖了2个周,就给拒了。。。拒了。。莫名其妙的给拒了,也就是说4个审稿人同意,一个不同意,给拒。。。按照这种无限找审稿人的做法,总有一个不认可你手稿的人,然后其他审稿人的意见都不听,直接给拒稿。<br>来来回回四个月,修改了七八次,润色也按照他们的要求做了,最后给你拒稿。给的理由极其不能让人信服。申诉都没地方去,这种杂志在开涮作者么?审稿就是个过场,编辑决定一切!希望投稿的人一些明灯,谨慎投稿。<br>另外,这个杂志已经铁定的中科院3区以下了,据不可靠消息中信所2021年也将该杂志列为预警名单。大家还是谨慎吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed955712032, createdName=ms1000001673566375, createdTime=Sat Mar 05 11:21:23 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227036, encodeId=bdd2122e0365c, content=问一下大家,是所有审稿人都审完了才可以提交修改后的文章是吧,交互论坛也没有开。目前只收到一个审稿人的意见,审稿进度显示Review is ongoing. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKiboeh23vhCNj6mpgnVvaMuttg0XFtg3tYNqn49fg91icLTbLlwDoqianeQXxwHvpe4mg4hpUM0ibh5w/132, createdBy=76fc2204943, createdName=飞天小女警, createdTime=Fri Jun 17 14:50:34 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056882, encodeId=895d1056882f9, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;基因;生物信息<br>经验分享:请问投稿时作者顺序把通讯弄成一作了怎么办,和手稿不一致,还没来的及跟编辑说,文章就已接收了,还没proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29775484328, createdName=wqqqqq, createdTime=Sat Oct 02 01:29:47 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205097, encodeId=6fa4120509e4b, content=偏重的研究方向:肺肿瘤<br>经验分享:请问非肿瘤纯生信还收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJhnQU5GWxeXOMO5JFcfQjuTfhjmpntBHASUp6pIzh7SfFPvNvhd9FNQyib6vKGJFicHLUhobumt2lQ/132, createdBy=01921810021, createdName=ms6239257544501925, createdTime=Wed Mar 23 03:21:54 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055926, encodeId=4d36105592603, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2950.0<br>偏重的研究方向:基因<br>经验分享:已经通过三个reviewers了;<br>等待associated editor的答复,<br>已经3天了,不知道还要多久啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47905578868, createdName=ms3000001689908876, createdTime=Wed Sep 29 08:25:10 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589932, encodeId=e5965899321f, content=请问一下,你选择的是哪位助理编辑呢<span class="quote">136me530613(暂无昵称) 2020-04-06 00:00:00 发表:<br>Received date: 17 Jan 2020 Editorial assignment start date: 20 Jan 2020 Independent review start date: 30 Jan 2020 Interactive review activated date: 22 Feb 2020 Review finalized date: 02 Apr 2020 Final validation date: 06 Apr 2020 分享下第二篇的速度,感觉比第一篇快,之前选了一个冷门版块,所以稍微慢点。总得来说非常好中,即时因子估计有3.2,现在加紧灌吧。</span>, beContent=136me530613(暂无昵称) 2020-04-06 00:00:00 发表: Received date: 17 Jan 2020 Editorial assignment start date: 20 Jan 2020 Independent review start date: 30 Jan 2020 Interactive review activated date: 22 Feb 2020 Review finalized date: 02 Apr 2020 Final validation date: 06 Apr 2020 分享下第二篇的速度,感觉比第一篇快,之前选了一个冷门版块,所以稍微慢点。总得来说非常好中,即时因子估计有3.2,现在加紧灌吧。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a93b5330592, createdName=148cb1c4m26(暂无昵称), createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001531, encodeId=29e8100153175, content=审了几个月说我没发原始结果给他,发给了给他又说没收到,好不容易审稿修回,竟然被他拒了,没有理由的拒稿,由主编直接拒掉。超级水刊,下次再也不投,没见过这么垃圾的杂志。拉入黑名单, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f1135538142, createdName=caixiangsheng, createdTime=Wed Jul 21 22:49:14 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922417, encodeId=f67592241eee, content=大佬们纯生信还收嘛?让补实验还是直接拒稿?求告知, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=ms9000000284734747, createdTime=Wed Feb 03 10:35:30 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587238, encodeId=234158e238eb, content=我现在,第6个reviewer了。第一个提出大修,我修回去后,他竟然自动退出审稿了!!!任性!!!接着就是分配给第2,3个,他们,没有时间审。第4,5小修后,同意接收刊发。然而,这个时候突然冒出来第6个审稿人,非得要我用人的肾脏组织验证,我想说,我哪里来人的肾脏组织啊!我直接回复没有人体标本。就看上天保佑了!这么多审稿人,简直是要了命了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInv9SLAL0ztdtz7Uiax0cnwHGiblwiaUmkUmjXgHC0g3u5Bf7Tib6V2hpqnNbhKuNHFZYXa9JVqNBepg/132, createdBy=c01f1932823, createdName=地方, createdTime=Mon Mar 23 20:53:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574552, encodeId=923f5e4552af, content=7-22投稿,7-24转到另一个section,然后进入编辑处理阶段,8-8十几天没有任何消息,连编辑都没指定, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/27/dc7b280f49af7fee2e92128f03a39234.jpg, createdBy=d2d11969271, createdName=hongweicheng, createdTime=Thu Aug 08 00:00:00 CST 2019, time=2019-08-08, status=1, ipAttribution=)]
    2019-08-08 hongweicheng

    7-22投稿,7-24转到另一个section,然后进入编辑处理阶段,8-8十几天没有任何消息,连编辑都没指定

    5

    展开5条回复
共500条页码: 4/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分